Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Ken Herrmann

Director at Aktis Oncology, Inc. (AKTS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $197K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 21SEC AKTSAktis Oncology, Inc. Sell 3,5061,350 held (−72%) $24.56 $86K -38.7%
Jul 21SEC AKTSAktis Oncology, Inc. Sell 1,350 $24.56 $33K -38.7%
Jul 20SEC AKTSAktis Oncology, Inc. Sell 3,065 $25.21 $77K -40.3%
  • Sell

    Director Ken Herrmann sold $86K of AKTS at $24.56 — cuts the stake by 72%.